Published in Br J Psychiatry on January 01, 1985
Subclinical epileptiform process in patients with unipolar depression and its indirect psychophysiological manifestations. PLoS One (2011) 0.78
Classifying seizures and epilepsies: limits of science and semantics. Epilepsy Curr (2011) 0.76
Persistent psychogenic déjà vu: a case report. J Med Case Rep (2014) 0.75
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry (2000) 5.21
Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res (1997) 4.04
Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry (2009) 3.64
Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci (1995) 3.56
Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry (1997) 3.02
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand (2007) 2.89
Calcific neurocysticercosis and epileptogenesis. Neurology (2004) 2.57
Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences. Arch Gen Psychiatry (1996) 2.53
Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry (1995) 2.53
Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry (2008) 2.50
Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Mol Psychiatry (2008) 2.49
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord (2001) 2.43
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry (2001) 2.38
Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry (1995) 2.26
Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport (1995) 2.06
ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry. Mol Psychiatry (2011) 2.05
Description of the Genetic Analysis Workshop 11 Collaborative Study on the Genetics of Alcoholism. Genet Epidemiol (1999) 2.01
Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry (1978) 1.88
Increasing effects of repetitive cocaine administration in the rat. Nature (1976) 1.85
Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry (2000) 1.66
Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. J Neuropsychiatry Clin Neurosci (1996) 1.60
Addition of lithium carbonate to carbamazepine: hematological and thyroid effects. Am J Psychiatry (1990) 1.55
Ultra-rapid and ultradian cycling in bipolar affective illness. Br J Psychiatry (1996) 1.54
Conjoint and extended neural networks for the computation of speech codes: the neural basis of selective impairment in reading words and pseudowords. Cereb Cortex (2001) 1.46
Gender differences in regional cerebral blood flow during transient self-induced sadness or happiness. Biol Psychiatry (1996) 1.46
Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry (2001) 1.46
Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. J Clin Psychopharmacol (1998) 1.46
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med (1986) 1.45
Quantitative trait loci analysis of human event-related brain potentials: P3 voltage. Electroencephalogr Clin Neurophysiol (1998) 1.43
Rash complicating carbamazepine treatment. J Clin Psychopharmacol (1994) 1.42
Association of the kappa-opioid system with alcohol dependence. Mol Psychiatry (2006) 1.42
Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder. Am J Psychiatry (1997) 1.41
Impaired recognition of affect in facial expression in depressed patients. Biol Psychiatry (1992) 1.40
The cyclic dilemma: organic, functional, and environmental interaction in a young teenager. J Am Acad Child Adolesc Psychiatry (1995) 1.39
Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biol Psychiatry (2000) 1.38
Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864. Mol Pharmacol (1982) 1.38
Fatal infection with Aeromonas hydrophila in a patient with acute myelogenous leukemia. Ann Intern Med (1967) 1.37
Quenching revisited: low level direct current inhibits amygdala-kindled seizures. Exp Neurol (1998) 1.36
Hemispheric lateralization of functions related to emotion. Brain Cogn (1986) 1.33
A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol (2000) 1.33
Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry (1999) 1.33
Regional brain activity when selecting a response despite interference: An H2 (15) O PET study of the stroop and an emotional stroop. Hum Brain Mapp (1994) 1.33
Effects of stress on neurotrophic factor expression in the rat brain. Ann N Y Acad Sci (1995) 1.31
The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand Suppl (1985) 1.31
Regional brain activity during transient self-induced anxiety and anger in healthy adults. Biol Psychiatry (1999) 1.28
Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol Med (2000) 1.24
Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency. Neurology (2009) 1.23
Genome-wide association study of conduct disorder symptomatology. Mol Psychiatry (2010) 1.22
Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry (1973) 1.21
Prospective assessment of menstrually related mood disorders. Am J Psychiatry (1984) 1.21
Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). J Neuropsychiatry Clin Neurosci (1997) 1.20
Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance. Life Sci (1980) 1.20
Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord (1986) 1.20
Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Am J Psychiatry (1982) 1.19
Cerebral metabolism and depression in patients with complex partial seizures. Arch Neurol (1992) 1.19
Conditioning and sensitisation in the longitudinal course of affective illness. Br J Psychiatry (1986) 1.18
Brain regions involved in recognizing facial emotion or identity: an oxygen-15 PET study. J Neuropsychiatry Clin Neurosci (1993) 1.16
Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology (1999) 1.16
A preliminary study of acute responses to clamped alcohol concentration and family history of alcoholism. Alcohol Clin Exp Res (1999) 1.15
Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. J Clin Endocrinol Metab (1991) 1.11
Understanding emotional prosody activates right hemisphere regions. Arch Neurol (1996) 1.11
The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. J Affect Disord (2001) 1.11
Regional cerebral blood flow correlated with flashback intensity in patients with posttraumatic stress disorder. Biol Psychiatry (2001) 1.11
Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. Am J Psychiatry (1997) 1.11
Anxiety proneness linked to epistatic loci in genome scan of human personality traits. Am J Med Genet (1998) 1.11
Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 1, 6, 8, 10, and 12. Am J Med Genet (1997) 1.10
The clinical phenomenology of multiple personality disorder: review of 100 recent cases. J Clin Psychiatry (1986) 1.10
The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry (2000) 1.09
A genome-wide screen for genes influencing conduct disorder. Mol Psychiatry (2004) 1.07
Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry (1980) 1.07
Effects of vasopressin on human memory functions. Science (1981) 1.07
Abnormal facial emotion recognition in depression: serial testing in an ultra-rapid-cycling patient. Behav Modif (1998) 1.07
Quenching: inhibition of development and expression of amygdala kindled seizures with low frequency stimulation. Neuroreport (1995) 1.06
Effect of lithium carbonate on memory processes of bipolar affectively ill patients. Psychopharmacology (Berl) (1979) 1.05
Preliminary evidence of the reliability and validity of the prospective life-chart methodology (LCM-p). J Psychiatr Res (1998) 1.03
Drug-environment interaction: context dependency of cocaine-induced behavioral sensitization. Life Sci (1981) 1.03
Cortisol hypersecretion and cognitive impairment in depression. Arch Gen Psychiatry (1984) 1.03
Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology (Berl) (1980) 1.02
Depression, anxiety, and temporal lobe epilepsy. Laterality of focus and symptoms. Arch Neurol (1990) 1.02
Chronic caffeine consumption increases the number of brain adenosine receptors. Life Sci (1983) 1.02
Replication and meta-analysis of TMEM132D gene variants in panic disorder. Transl Psychiatry (2012) 1.02
Salivary cortisol: a practical method for evaluation of adrenal function. Biol Psychiatry (1988) 1.02
Corpus callosum dimensions measured by magnetic resonance imaging in bipolar affective disorder and schizophrenia. Biol Psychiatry (1989) 1.01
CRF-induced seizures and behavior: interaction with amygdala kindling. Brain Res (1986) 1.00
Thrombocytopenia and alcoholism. Ann Intern Med (1968) 1.00
Age-related changes in sleep in depressed and normal subjects. Psychiatry Res (1981) 0.99
Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report. Acta Psychiatr Scand (2014) 0.99
Thinking disorder in depression. Arch Gen Psychiatry (1983) 0.99
Cocaine, kindling, and psychosis. Am J Psychiatry (1976) 0.99
Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry (2000) 0.98
Family-based genome-wide association study of frontal θ oscillations identifies potassium channel gene KCNJ6. Genes Brain Behav (2012) 0.98
Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder. J Affect Disord (1999) 0.98
The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol (1995) 0.97
Context-dependent cocaine sensitization: differential effect of haloperidol on development versus expression. Pharmacol Biochem Behav (1989) 0.97
Cocaine psychoses: a continuum model. Am J Psychiatry (1975) 0.96